Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Brief
"On January 23, 2025, the Ministry of Health and Welfare (MOHW) hosted the 1st Advanced Regenerative Medicine and Advanced Biopharmaceutical Deliberation Committee. The committee reviewed two clinical research plans, with one deemed suitable for approval and the other rejected. The approved study aims to investigate the efficacy of a combined treatment involving mFOLFIRINOX and autologous cytokine-induced killer cells for patients with advanced pancreatic cancer."
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
